JLL names Mark Seliskar new head of Life Sciences operations in Canada
CHICAGO, April 15, 2026 – JLL announced today that it has hired Mark Seliskar to lead JLL's Life Sciences operations across the Canadian region. In this role, he will bring his deep expertise in pharmaceutical and life sciences facilities management to support clients navigating complex regulatory requirements and operational challenges in highly controlled environments.
As a licensed Professional Engineer, Seliskar will leverage his operational knowledge to build and lead multidisciplinary teams to deliver integrated facilities management solutions for pharmaceutical and life sciences clients with sites in Canada. His proven track record includes managing GMP facilities, driving compliance excellence and delivering cost efficiencies. Additionally, he has led engineering and maintenance departments, completed BLA submissions and FDA pre-licensing site inspections and managed operations for bio-containment facilities.
“Mark’s appointment as the new Life Sciences Regional Lead for Canada strengthens our ability to deliver excellence in facilities management and operational support for our clients,” said Pam Paddock, Managing Director, Life Sciences at JLL. “His extensive expertise spanning sterile GMP manufacturing facilities, capital project management, validation and compliance remediation makes him exceptionally well-suited to lead our Canadian Life Sciences operations.”
“Mark’s addition reflects our continued investment in building JLL’s Life Sciences brand globally,” added Kevin Wayer, Division President, Global – Life Sciences at JLL. “By attracting top-tier talent with vast industry expertise in key markets like Canada, we demonstrate our commitment to establishing JLL as the partner of choice for pharmaceutical and biotechnology companies seeking trusted expertise worldwide.”
Seliskar is based in Montreal and reports to Paddock. Prior to joining JLL, Seliskar served as General Manager at Sodexo Québec, where he was the subject matter expert for Pharma/Life Sciences operations and a key resource for client-facing business development activities in the Canadian market. Previously, he served as Senior Manager of Maintenance & Engineering at Jubilant HollisterSteir and as Engineer Manager/Director of Engineering at Telesta Therapeutics, where he led engineering departments and managed new installation and upgrade projects for GMP manufacturing equipment and facilities.
“I'm excited to join JLL at a time when the Life Sciences sector continues to grow and evolve across Canada,” Seliskar said. “JLL's scale, client relationships and integrated platform create a unique opportunity to deliver exceptional value to clients as they navigate the intricacies of pharmaceutical and life sciences operations.”
“We are delighted to be adding Mark to the team,” added Scott Barras, Head of JLL’s Work Dynamics’ Business in Canada. “The Life Sciences industry in Canada has been a focus for JLL for some time and having him join us is further evidence of our commitment in this space.”
Seliskar succeeds Jean Francois (JF) Chapdelaine, who has been an integral part of JLL since 2009, who is transitioning into retirement.
JLL’s vision is to reimagine the world of real estate, creating, finding, locating and operating safe and amazing spaces. With persistent curiosity in advancing humanity, JLL’s globally connected Life Sciences team of 3,600+ experienced professionals tailor unique strategies to help biotechnology, pharmaceutical, medical devices organizations, investors and developers turn science fiction into science fact. JLL brings deep understanding of location analytics, project management, research advisory, workplace experience, financial incentives, transaction management, capital markets, real estate strategy and technology, facilities management, regulatory compliance and quality, and more. Its solutions help fuel innovation, enhance efficiency, improve financial performance and attract and retain top talent. Its team is trained and certified to operate within office and critical environments of lab and manufacturing space. To learn more, visit
For more news, videos and research resources on JLL, please visit JLL’s newsroom.
About JLL
JLL (NYSE:JLL) is a leading global commercial real estate services and investment management company with annual revenue of $26.1 billion, operations in over 80 countries and a global workforce of more than 113,000 as of December 31, 2025. For over 200 years, clients have trusted JLL, a Fortune 500® company, to help them confidently buy, build, occupy, manage and invest across a variety of industries and property types, including office, industrial, hotel, multi-family, retail and data center properties. Driven by our purpose to shape the future of real estate for a better world, we help our clients, people and communities SEE A BRIGHTER WAY. Powered by rich global datasets and leading technology capabilities, we provide coordinated, end-to-end delivery of real estate services for a broad range of global clients who represent a wide variety of industries. Through LaSalle Investment Management, we invest for clients on a global basis in both private assets and publicly traded real estate securities. For further information, visit jll.com.